CIISX
Price
$14.89
Change
-$0.27 (-1.78%)
Updated
Dec 18 closing price
HWTIX
Price
$9.30
Change
-$0.19 (-2.00%)
Updated
Dec 18 closing price
Ad is loading...

CIISX vs HWTIX

Header iconCIISX vs HWTIX Comparison
Open Charts CIISX vs HWTIXBanner chart's image
Causeway International Small Cap Instl
Price$14.89
Change-$0.27 (-1.78%)
VolumeN/A
CapitalizationN/A
Hotchkis & Wiley Intl Sm Cp Dvsfd Val I
Price$9.30
Change-$0.19 (-2.00%)
VolumeN/A
CapitalizationN/A
CIISX vs HWTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIISX vs. HWTIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIISX is a Hold and HWTIX is a StrongSell.

FUNDAMENTALS
Fundamentals
CIISX has more cash in the bank: 235M vs. HWTIX (4.58M). CIISX pays higher dividends than HWTIX: CIISX (5.84) vs HWTIX (4.03). CIISX was incepted earlier than HWTIX: CIISX (10 years) vs HWTIX (4 years). CIISX is a more actively managed with annual turnover of: 133.00 vs. HWTIX (78.00). HWTIX has a lower initial minimum investment than CIISX: HWTIX (250000) vs CIISX (1000000). CIISX annual gain was more profitable for investors over the last year : 13.93 vs. HWTIX (-11.87).
CIISXHWTIXCIISX / HWTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years4 years-
Gain YTD11.307-15.218-74%
Front LoadN/AN/A-
Min. Initial Investment1000000250000400%
Min. Initial Investment IRAN/AN/A-
Net Assets235M4.58M5,133%
Annual Yield % from dividends5.844.03145%
Returns for 1 year13.93-11.87-117%
Returns for 3 years30.12-9.83-306%
Returns for 5 years58.24N/A-
Returns for 10 years105.21N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CKPT3.710.32
+9.59%
Checkpoint Therapeutics
WALD3.900.11
+2.90%
Waldencast plc
SUZ10.430.10
+0.97%
Suzano SA
QTWO104.54-0.84
-0.80%
Q2 Holdings
LYRA0.18N/A
-1.94%
Lyra Therapeutics